Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Inflammation & Allergy Drug Targets|March 23, 2013
Predicting drug efficacy using integrative models for chronic respiratory diseasesChristopher S Stevenson, Sriram Sridhar, Jonathan E PhillipsPulmonary Pharmacology & Therapeutics|October 26, 2011
Bleomycin induced lung fibrosis increases work of breathing in the mouseJonathan E Phillips, Ruoqi Peng, Lisa Burns, et al.Journal of Aerosol Medicine and Pulmonary Drug Delivery|April 26, 2016
Btk Inhibitor RN983 Delivered by Dry Powder Nose-only Aerosol Inhalation Inhibits Bronchoconstriction and Pulmonary Inflammation in the Ovalbumin Allergic Mouse Model of AsthmaJonathan E Phillips, Lorena Renteria, Lisa Burns, et al.Plos One|April 9, 2013
Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" diseaseRuoqi Peng, Sriram Sridhar, Gaurav Tyagi, et al.Frontiers in Pharmacology|April 1, 2020
Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory DiseasesJonathan E PhillipsBiorxiv : the Preprint Server for Biology|August 7, 2023
The Hippo kinase cascade regulates a contractile cell behavior and cell density in a close unicellular relative of animalsJonathan E Phillips, Duojia PanElife|March 22, 2024
The Hippo kinase cascade regulates a contractile cell behavior and cell density in a close unicellular relative of animalsJonathan E Phillips, Duojia PanExpert Review of Respiratory Medicine|May 19, 2010
Preclinical animal models of asthma and chronic obstructive pulmonary diseaseChristopher S Stevenson, Maria G BelvisiPulmonary Pharmacology & Therapeutics|January 29, 2013
Is intrinsic aerobic exercise capacity a determinant of COPD susceptibility?Christopher S Stevenson, Liang Yew-BoothPharmacology & Therapeutics|November 16, 2010
Moving towards a new generation of animal models for asthma and COPD with improved clinical relevanceChristopher S Stevenson, Mark A BirrellPageof 11